Kontaktujte nás | Jazyk: čeština English
Název: | What is uric acid concentration in urine in patients with uric acid kidney stones? - a case study | ||||||||||
Autor: | Šálek, Tomáš; Musil, Pavel; Zlatníková, Irena | ||||||||||
Typ dokumentu: | Recenzovaný odborný článek (English) | ||||||||||
Zdrojový dok.: | Biochemia Medica. 2025, vol. 35, issue 3, p. 31001 | ||||||||||
ISSN: | 1330-0962 (Sherpa/RoMEO, JCR) | ||||||||||
Journal Impact
This chart shows the development of journal-level impact metrics in time
|
|||||||||||
DOI: | https://doi.org/10.11613/BM.2025.031001 | ||||||||||
Abstrakt: | This case report describes a patient with uric acid kidney stones. Alkalization therapy using mainly potassium citrate is the first-choice treatment. When hyperuricosuria > 4 mmol/24 hours is present, xanthine oxidase inhibitors are added. It implies that accurate urine uric acid measurement is of high importance. Uric acid was measured in a 24-hour collection and a second-morning sample. Urine uric acid was measured after sample alkalization to pH > 6.5 and heating to 56 °C for 10 minutes, and for educational reasons without sample treatment. The uric acid excretion in the sample without alkalization in the 24-hour collection was 2.436 mmol, after alkalization, the excretion was 4.650 mmol/24 hours. Sample alkalization led to a prescription for xanthine oxidase inhibitor medication that is indicated as the second-line therapy when hyperuricosuria > 4 mmol/24 hours is present. This case study shows how the correct preanalytical phase is essential for medical decision-making. This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine | ||||||||||
Plný text: | https://www.biochemia-medica.com/en/journal/35/3/10.11613/BM.2025.031001/fullArticle | ||||||||||
Zobrazit celý záznam |